Brad L. Tade

Chief Financial Officer, ADMA Biologics (United States).

Companies

ADMA Biologics (United States)Chief financial officer Jul 26, 2024 to Feb 26, 2026¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 19, 2026Shares withheld for tax 6,479 shares at $16.32 of ADMA Biologics (United States)²
Jul 24, 2025Shares withheld for tax 7,123 shares at $17.31 of ADMA Biologics (United States)³
Jun 26, 2025Shares withheld for tax 9,838 shares at $18.40 of ADMA Biologics (United States)⁴
Feb 26, 2025Shares withheld for tax 5,280 shares at $15.78 of ADMA Biologics (United States)⁵
Feb 19, 2025Granted 62,227 shares of ADMA Biologics (United States)⁶
Nov 22, 2024Sold 15,000 shares at $21.15 of ADMA Biologics (United States)⁷
Jul 24, 2024Granted 72,400 shares of ADMA Biologics (United States)⁸

The numbers on this page point here. Each one links to the record it came from.